The biotech industry must navigate complex regulatory environments, ethical considerations, and the need for sustainable and equitable access to these breakthrough technologies.
However, this journey is not without its challenges. The biotech industry must navigate complex regulatory environments, ethical considerations, and the need for sustainable and equitable access to these breakthrough technologies. The collaborations between smaller biotechs and larger pharmaceutical companies, the ethical deployment of AI in healthcare, and the responsible application of CRISPR technology, all require a balanced approach that considers the long-term implications of these advancements.